Tenders/MH-DEM-022026-PMA - 1

MH-DEM-022026-PMA - 1

MercurHosp ASBL

Published: Sep 21, 2026

Updated: Sep 21, 2026

Source: TED - Tenders Electronic Daily (EU)

About This Opportunity

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Belgium, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

This procurement, identified by the reference MH-DEM-022026-PMA - 1, concerns the acquisition of injectable GnRH antagonists. GnRH (Gonadotropin-Releasing Hormone) antagonists are a class of pharmaceutical compounds used in various medical treatments, often related to reproductive health or hormone-dependent conditions. The contracting authority, based in Belgium, is seeking a reliable supply of these specific pharmaceutical products. The tender is likely for a public health institution, hospital, or a government agency responsible for healthcare procurement. Typical requirements for such a tender include the ability to supply high-quality, certified pharmaceutical products that meet stringent regulatory standards (e.g., EMA approval). Bidders must provide detailed product specifications, proof of manufacturing authorization, compliance with Good Manufacturing Practices (GMP), and potentially a secure and efficient supply chain. The evaluation criteria will focus on the quality and compliance of the offered products, the supplier's reliability, delivery capabilities, and price. This is a specialized medical supply tender requiring adherence to strict pharmaceutical regulations.

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on September 21, 2026. Last refreshed today. Original language: French. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About MercurHosp ASBL

MercurHosp ASBL has issued 40 procurement notices on BidsFactory, including 5 currently open and 3 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Architecture & Engineering Services. All notices are published for Belgium. Notices are distributed via Belgium e-Procurement and TED - Tenders Electronic Daily (EU). Most recent publication: September 21, 2026.

Frequently asked questions about this tender

Who is the contracting authority?

This notice was issued by MercurHosp ASBL in Belgium. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in Belgium. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.